Standardizing Immunoassays for Global Vaccine Trials
Standardizing Immunoassays for Global Vaccine Trials How to Standardize Immunoassays Across Global Vaccine Trials Why Immunoassay Standardization Matters in Multi-Country Studies In global vaccine trials, a single scientific question is answered by data streamed from many clinics and multiple laboratories. Without deliberate standardization, an observed “difference” between treatment groups or age cohorts can be an…
Read More “Standardizing Immunoassays for Global Vaccine Trials” »